Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Blood
|
May 29, 2000
Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG
A Moreau, S Lacroix-Desmazes, N Stieltjes, et al.
Blood
|
July 1, 1986
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease
H R Gralnick, M E Rick, L P McKeown, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1976
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein
J P Caen, A T Nurden, C Jeanneau, et al.
Nature Medicine
|
September 2, 1999
Catalytic activity of antibodies against factor VIII in patients with hemophilia A
S Lacroix-Desmazes, A Moreau, Sooryanarayana, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1988
Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates
A Parquet, B Boneu, C Bosser, et al.
Revue Du Rhumatisme (English Ed.)
|
May 26, 1998
Nonsurgical synovectomy in the treatment of arthropathy in Von Willebrand's Disease
G Salis, P Molho, P Verrier, et al.
Journal of Immunological Methods
|
March 31, 1998
Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII
A Laulan, A Sauger, C Germain, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII
Y Sultan, G C White, A Aronstam, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Long-term survival of HIV-infected patients with haemophilia
N Stieltjes, Y Sultan, C Rothschild, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 14, 2000
Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children
R W Frenck, I Nakhla, Y Sultan, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Blood
|
May 29, 2000
Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG
A Moreau, S Lacroix-Desmazes, N Stieltjes, et al.
Blood
|
July 1, 1986
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease
H R Gralnick, M E Rick, L P McKeown, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1976
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein
J P Caen, A T Nurden, C Jeanneau, et al.
Nature Medicine
|
September 2, 1999
Catalytic activity of antibodies against factor VIII in patients with hemophilia A
S Lacroix-Desmazes, A Moreau, Sooryanarayana, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1988
Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates
A Parquet, B Boneu, C Bosser, et al.
Revue Du Rhumatisme (English Ed.)
|
May 26, 1998
Nonsurgical synovectomy in the treatment of arthropathy in Von Willebrand's Disease
G Salis, P Molho, P Verrier, et al.
Journal of Immunological Methods
|
March 31, 1998
Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII
A Laulan, A Sauger, C Germain, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1986
Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII
Y Sultan, G C White, A Aronstam, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Long-term survival of HIV-infected patients with haemophilia
N Stieltjes, Y Sultan, C Rothschild, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 14, 2000
Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children
R W Frenck, I Nakhla, Y Sultan, et al.
Page
of 19